Plains GP (NYSE:PAGP) Releases Quarterly Earnings Results, Misses Expectations By $0.11 EPS

Plains GP (NYSE:PAGP) announced its quarterly earnings data on Friday. The pipeline company reported $0.20 EPS for the quarter, missing the consensus estimate of $0.31 by ($0.11), Zacks reports. Plains GP had a return on equity of 1.15% and a net margin of 0.35%. The company had revenue of $12.93 billion for the quarter, compared to analyst estimates of $13.70 billion. During the same period last year, the business earned $0.25 EPS.

Plains GP Stock Performance

PAGP traded down $0.59 during trading hours on Friday, hitting $18.40. The stock had a trading volume of 1,759,358 shares, compared to its average volume of 1,396,834. The company’s fifty day simple moving average is $18.71 and its 200 day simple moving average is $18.03. Plains GP has a 1 year low of $14.71 and a 1 year high of $20.10. The stock has a market cap of $3.63 billion, a PE ratio of 20.91 and a beta of 1.54. The company has a quick ratio of 0.88, a current ratio of 0.97 and a debt-to-equity ratio of 0.49.

Plains GP Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 14th. Stockholders of record on Wednesday, July 31st will be paid a dividend of $0.3175 per share. This represents a $1.27 dividend on an annualized basis and a dividend yield of 6.90%. The ex-dividend date is Wednesday, July 31st. Plains GP’s payout ratio is 144.32%.

Wall Street Analyst Weigh In

PAGP has been the topic of a number of recent research reports. Barclays increased their target price on Plains GP from $16.00 to $18.00 and gave the stock an “underweight” rating in a report on Friday, April 12th. Wells Fargo & Company increased their target price on Plains GP from $19.00 to $20.00 and gave the stock an “overweight” rating in a report on Wednesday, May 8th. StockNews.com cut Plains GP from a “buy” rating to a “hold” rating in a report on Thursday, May 9th. Morgan Stanley increased their target price on Plains GP from $19.00 to $20.00 and gave the stock an “overweight” rating in a report on Monday, June 10th. Finally, UBS Group raised their price objective on Plains GP from $22.00 to $23.00 and gave the company a “buy” rating in a research note on Friday, April 12th. Two analysts have rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $20.11.

Plains GP Company Profile

Plains GP Holdings, L.P., through its subsidiary, Plains All American Pipeline, L.P., owns and operates midstream infrastructure systems in the United States and Canada. It operates in two segments, Crude Oil and Natural Gas Liquids (NGLs). The company engages in the gathering and transporting crude oil and NGLs using pipelines, gathering systems, and trucks.